Concepedia

Author

Martine Klausmann

Goethe University Frankfurt

Also Known As

M Klausmann, M. Klausmann, Martine Klausmann, Ulrich Hutzschenreuter, W. Hollburg

45

Publications

616

Citations

12

H-Index

16

Concepts

All Affiliations

Goethe University FrankfurtHeidelberg UniversityUniversität HamburgUniversity Medical Center Hamburg-EppendorfKlinikum Aschaffenburg
MK

About

Martine Klausmann is an author at Goethe University Frankfurt specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

150

2

Immunology

3

3

129

3

Health Sciences

1

1

44

4

Cell Biology

1

1

12

5

Pharmacology

1

1

21

Martine Klausmann

×

11

Publications

479

Citations

11

H-Index

YearCitations

Effects of recombinant human interleukin-3 in aplastic anemia

Arnold Ganser, A Lindemann, G. Seipelt,

Blood

1990

123

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos,

Clinical Lymphoma Myeloma & Leukemia

2018

89

Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b

Rudolf Weide, K. Ehlenz, W. Lorenz,

Annals of Hematology

1996

73

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek,

Journal of Clinical Oncology

2024

48

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis,

The Lancet Haematology

2022

44

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry

Judith Gecht, Ioannis Tsoukakis, Kim Kricheldorf,

Cancers

2021

23

Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor α levels

W.-K. Hofmann, G. Seipelt, Oliver G. Ottmann,

Annals of Hematology

2000

21

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial

Sébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz,

Clinical Lymphoma Myeloma & Leukemia

2018

20

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)

Jürgen Wehmeyer, Christoph Losem, Stephan Schmitz,

European Journal Of Haematology

2018

13

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Andreas Burchert, Christian Michel, Stephan Metzelder,

Blood

2022

13

Page 1